13F filer · CIK 1037792 ↗

Paradigm Capital Management Inc

You are looking at Q4 2025. See the latest, Q2 2026 →

Reported value

$2.38B

+3.0% on the quarter before

Positions

116

3 new · 13 sold out

Top 10

58.9%

of the value

Est. gain

+$91.2M

on stocks held all quarter

Est. return

+4.2%

on those stocks since Q3 2025

Filed

Feb 12, 2026

On SEC EDGAR ↗

Positions as of Dec 31, 2025, from Paradigm Capital Management Inc's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

  • New
  • Added
  • Cut
  • Same
  • Options

Each tile is a position, sized by its share, colored by what the fund did with it since Q3 2025. Striped tiles are options.

92 others18%
Broadcom12%
Fabrinet10%
Modine8.3%Onto Innovation7.5%Jabil5.4%
Extreme Networks3.5%
Globus Medical3.5%
Ducommun Inc3.1%
Veeco Instruments2.9%
Enersys2.9%
Insight Enterprises2.8%
Enviri Corp2.7%
Ensign Group, Inc.2.5%
Orthofix Medical Inc.2.1%
Entegris1.9%
Pennant Group Inc.1.7%
Calix Inc1.5%
Integra Lifesciences Holdings Corp1.4%
Enovis Corporation1.2%
Dentsply Sirona, Inc.1.2%
Ribbon Communications Inc1.0%
Quidel Corp1.0%
Cerence0.9%
0.9%

Largest buys

Since Q3 2025, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Insight Enterprises~$17.4MAdded · 2.9% → 2.8%+214,064 shares
  2. Dentsply Sirona, Inc.~$16.6MAdded · 0.5% → 1.2%+1,456,249 shares
  3. MaxLinear~$12.8MAdded · 0.1% → 0.6%+734,875 shares
  4. Helen Of Troy Limited~$12.0MNew · 0.0% → 0.5%+564,200 shares
  5. Adtran Inc~$8.3MAdded · 0.1% → 0.4%+949,909 shares
  6. Trubridge, Inc.~$4.8MAdded · 0.1% → 0.3%+216,144 shares
  7. Penguin Solutions Inc~$4.1MAdded · 0.8% → 0.8%+207,349 shares
  8. Bath & Body Works, Inc.~$4.0MNew · 0.0% → 0.2%+200,000 shares
  9. Caleres Inc~$3.1MAdded · 0.4% → 0.5%+256,155 shares
  10. Cohu Inc.~$2.3MAdded · 0.7% → 0.9%+99,998 shares

Largest sells

Since Q3 2025, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Tactile Systems Technology~$23.3MCut · 0.9% → 0.9%−801,801 shares
  2. Concentrix Corp~$22.1MCut · 1.2% → 0.2%−530,500 shares
  3. FormFactor~$8.4MCut · 0.3% → 0.1%−150,000 shares
  4. Pacs Group, Inc.~$7.3MSold out · 0.3% → 0.0%−532,200 shares
  5. Xerox Corp~$6.2MCut · 0.6% → 0.1%−2,611,200 shares
  6. Enviri Corp~$4.5MCut · 2.1% → 2.7%−248,602 shares
  7. Enovis Corporation~$4.3MCut · 1.6% → 1.2%−161,078 shares
  8. Nn, Inc.~$3.4MCut · 0.3% → 0.0%−2,658,262 shares
  9. Integer Holdings~$3.3MSold out · 0.1% → 0.0%−32,200 shares
  10. Best Buy Co~$3.2MSold out · 0.1% → 0.0%−41,900 shares

Holdings

As of Dec 31, 2025. Changes are in shares against Sep 30, 2025, so a price move alone never reads as a buy or a sale.

Positions, sorted by share of the portfolio
HoldingValue
BroadcomCOM · shares 0% · price +4.9%11.8%$280.0M+$13.1M
FabrinetCOM · shares 0% · price +24.9%10.2%$241.5M+$48.1M
ModineCOM · shares −1.3% · price −6.1%8.3%$197.1M−$12.8M
Onto InnovationCOM · shares +1.2% · price +22.2%7.5%$177.7M+$31.9M
JabilCOM · shares 0% · price +5.0%5.4%$127.2M+$6.1M
Extreme NetworksCOM · shares +0.8% · price −19.4%3.5%$82.8M−$19.7M
Globus MedicalCOM · shares −0.1% · price +52.5%3.5%$82.6M+$28.4M
Ducommun IncCOM · shares 0% · price −1.0%3.1%$73.3M−$770,500
Veeco InstrumentsCOM · shares +1.7% · price −6.1%2.9%$68.6M−$4.4M
EnersysCOM · shares 0% · price +29.9%2.9%$68.4M+$15.7M
Insight EnterprisesCOM · shares +36% · price −28.2%2.8%$66.1M−$19.1M
Enviri CorpCOM · shares −6.6% · price +41.2%2.7%$63.5M+$18.5M
Ensign Group, Inc.COM · shares −0.00% · price +0.8%2.5%$59.9M+$492,062
Orthofix Medical Inc.COM · shares −1.2% · price +3.6%2.1%$50.1M+$1.7M
EntegrisCOM · shares +1.2% · price −8.9%1.9%$45.0M−$4.3M
Pennant Group Inc.COM · shares −0.8% · price +11.6%1.7%$39.8M+$4.1M
Calix IncCOM · shares 0% · price −13.8%1.5%$35.6M−$5.7M
Integra Lifesciences Holdings CorpCOM · shares +5.3% · price −13.3%1.4%$33.1M−$4.8M
Enovis CorporationCOM · shares −13% · price −12.2%1.2%$27.8M−$3.9M
Dentsply Sirona, Inc.COM · shares +155% · price −9.9%1.2%$27.4M−$1.2M
Ribbon Communications IncCOM · shares −4.9% · price −24.2%1.0%$24.0M−$7.7M
Quidel CorpCOM · shares −12% · price −3.0%1.00%$23.7M−$737,713
CerenceCOM · shares −0.7% · price −14.2%0.91%$21.7M−$3.6M
Tactile Systems TechnologyCOM · shares −52% · price +109.5%0.90%$21.4M+$11.2M
Cohu Inc.COM · shares +12% · price +14.5%0.90%$21.3M+$2.4M
Total · 116 positions100%$2.38B+$91.2M
The filing on SEC EDGAR ↗

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q3 2025 to Q4 2025: 113 stocks held throughout, up $91.2M (+4.2%).

  1. Fabrinet+$48.1M+25%
  2. Onto Innovation+$31.9M+22%
  3. Globus Medical+$28.4M+52%
  4. Enviri Corp+$18.5M+41%
  5. Enersys+$15.7M+30%
  6. Calix Inc−$5.7M−14%
  7. Ribbon Communications Inc−$7.7M−24%
  8. Modine−$12.8M−6%
  9. Insight Enterprises−$19.1M−28%
  10. Extreme Networks−$19.7M−19%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.

Reported value by quarter

The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.

$4.00B$2.00B$0
Q1 2016Q2 2026
Every quarter's filing
Each quarter's 13F filing, newest first
QuarterReported valueFiling
Q2 2026$3.67B+41%SEC ↗
Q1 2026$2.61B+10%SEC ↗
Q4 2025$2.38B+3%SEC ↗
Q3 2025$2.31B+12%SEC ↗
Q2 2025$2.05B+14%SEC ↗
Q1 2025$1.80B−17%SEC ↗
Q4 2024$2.16B−4%SEC ↗
Q3 2024$2.25B+3%SEC ↗
Q2 2024$2.19B+5%SEC ↗
Q1 2024$2.09B+9%SEC ↗
Q4 2023$1.92B+10%SEC ↗
Q3 2023$1.74B−0%SEC ↗
Q2 2023$1.75B+16%SEC ↗
Q1 2023$1.51B−0%SEC ↗
Q4 2022$1.51B+9%SEC ↗
Q3 2022$1.39B−6%SEC ↗
Q2 2022$1.47B−20%SEC ↗
Q1 2022$1.85B−17%SEC ↗
Q4 2021$2.24B+15%SEC ↗
Q3 2021$1.94B−7%SEC ↗
Q2 2021$2.08B+8%SEC ↗
Q1 2021$1.93B+15%SEC ↗
Q4 2020$1.67B+41%SEC ↗
Q3 2020$1.19B+9%SEC ↗
Q2 2020$1.09B+32%SEC ↗
Q1 2020$827.9M−36%SEC ↗
Q4 2019$1.30B+16%SEC ↗
Q3 2019$1.12B+2%SEC ↗
Q2 2019$1.10B−4%SEC ↗
Q1 2019$1.14B+12%SEC ↗
Q4 2018$1.02B−20%SEC ↗
Q3 2018$1.27B+3%SEC ↗
Q2 2018$1.24B+5%SEC ↗
Q1 2018$1.18B+1%SEC ↗
Q4 2017$1.17B+2%SEC ↗
Q3 2017$1.15B+4%SEC ↗
Q2 2017$1.11B+5%SEC ↗
Q1 2017$1.06B+3%SEC ↗
Q4 2016$1.03B+8%SEC ↗
Q3 2016$953.0M+16%SEC ↗
Q2 2016$820.6M−4%SEC ↗
Q1 2016$858.8MSEC ↗

Get the newsletter

The day's AI and market news, in your inbox every weekday.